Prakt. lékáren. 2018; 14(1): 19-21 | DOI: 10.36290/lek.2018.004

Lapacho – active compounds and therapeutic effects

Zdeňka Navrátilová
Katedra botaniky, Přírodovědecká fakulta UK Praha

Lapacho (Tabebuia impetiginosa) is a tropical evergreen tree originating from South America. Its bark is used in traditional medicineespecially for cancer, infections a immunity disorders, such as allergy, revmatism, and psoriasis. The main active compoundsof lapacho are quinones lapachol and β-lapachon and recent studies confirm its therapeutic effects. The most promising is theiranti-tumor and immunomodulatory activity. However, clinical trials are still lacking.

Keywords: Tabebuia impetiginosa, lapacho, traditional medicine, lapachol, β-lapachon, cancer

Published: March 24, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátilová Z. Lapacho – active compounds and therapeutic effects. Praktické lékárenství. 2018;14(1):19-21. doi: 10.36290/lek.2018.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Jeník J. Ekosystémy (Úvod do organizace zonálních a azonálních biomů). Karolinum 1998; 135 p.
    2. Balick MJ, Elisabetsky E, Laird SA. Medicinal Resources of the Tropical Forest: Biodiversity and Its Importance to Human Health. Columbia University Press 1994; 458 p.
    3. van Wyk B-E, Wink M. Medicinal Plants of the World. Timber Press 2005; 480 p.
    4. Duke JA. Duke's Handbook of Medicinal Plants of Latin America. CRC Press 2008; 832 p. Go to original source...
    5. Gómez Castellanos JR, Prieto JM, Heinrich M. Red Lapacho (Tabebuia impetiginosa) - a global ethnopharmacological commodity? J Ethnopharmacol. 2009; 121(1): 1-13. Go to original source... Go to PubMed...
    6. Block JB, Serpick AA, Miller W, Wiernik PH. Early clinical studies with lapachol (NSC-11905). Cancer Chemotherapy Reports Part 2. 1974; 4(4): 27-28.
    7. Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, Chen L. ?-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci Rep. 2017; 7(1): 2681. Go to original source... Go to PubMed...
    8. Jeon YJ, Bang W, Choi YH, Shim JH, Chae JI. Beta-lapachone suppresses non-small cell lung cancer proliferation through the regulation of specificity protein 1. Biol Pharm Bull. 2015; 38(9): 1302-1308. Go to original source... Go to PubMed...
    9. Kee JY, Han YH, Park J, Kim DS, Mun JG, Ahn KS, Kim HJ, Um JY, Hong SH. ?-lapachone inhibits lung metastasis of colorectal cancer by inducing apoptosis of CT26 cells. Integr Cancer Ther. 2016: 1-12. Go to original source... Go to PubMed...
    10. Kee JY, Han YH, Kim DS, Mun JG, Park SH, So HS, Park SJ, Park R, Um JY, Hong SH. ?-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway. PLoS One. 2017; 12(5): e0176937. Go to original source... Go to PubMed...
    11. Hussain H, Green IR. Lapachol and lapachone analogs: a journey of two decades of patent research (1997-2016). Expert Opin Ther Pat. 2017: 1-11. Go to original source... Go to PubMed...
    12. Fu SC, Chau YP, Lu KS, Kung HN. ?-lapachone accelerates the recovery of burn-wound skin. Histol Histopathol. 2011; 26(7): 905-914. Go to PubMed...
    13. Giacomelli I, Scartoni D, Fiammetta M, Baki M, Zei G, Muntoni C, Cappelli S, Greto D, Scoccianti S, Livi L. Oral lapacho-based medication: an easy, safe, and feasible support to prevent and/or reduce oral mucositis during radiotherapy for head and neck cancer. Nutr Cancer. 2015; 67(8): 1247-1253. Go to original source... Go to PubMed...
    14. Lee MH, Choi HM, Hahm DH, Her E, Yang HI, Yoo MC, Kim KS. Analgesic and anti-inflammatory effects in animal models of an ethanolic extract of Taheebo, the inner bark of Tabebuia avellanedae. Mol Med Rep. 2012; 6(4): 791-796. Go to original source... Go to PubMed...
    15. Byeon SE, Chung JY, Lee YG, Kim BH, Kim KH, Cho JY. In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae. J Ethnopharmacol. 2008; 119(1): 145-152. Go to original source... Go to PubMed...
    16. Müller K, Sellmer A, Wiegrebe W. Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth. J Nat Prod. 1999; 62(8): 1134-1136. Go to original source... Go to PubMed...
    17. Pinto CN, Dantas AP, De Moura KC, Emery FS, Polequevitch PF, Pinto MC, de Castro SL, Pinto AV. Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy. Arzneimittelforschung. 2000; 50(12): 1120-1128. Go to original source...
    18. Lima NM, Correia CS, Leon LL, Machado GM, Madeira Mde F, Santana AE, Goulart MO. Antileishmanial activity of lapachol analogues. Mem Inst Oswaldo Cruz. 2004; 99(7): 757-761. Go to original source... Go to PubMed...
    19. Macedo L, Fernandes T, Silveira L, Mesquita A, Franchitti AA, Ximenes EA. ?-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains. Phytomedicine. 2013; 21(1): 25-29. Go to original source... Go to PubMed...
    20. Park BS, Lee HK, Lee SE, Piao XL, Takeoka GR, Wong RY, Ahn YJ, Kim JH. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol. 2006; 105(1-2) : 255-262. Go to original source... Go to PubMed...
    21. Gardner Z, McMuffin M. American Herbal Products Association's Botanical Safety Handbook 2nd ed. CRC Press 2013; 1042 p. Go to original source...
    22. Mills S, Bone K. The Essential Guide to Herbal Safety. Churchill Livingston 2004; 704 p.
    23. Williamson EM, Driver S, Baxter K (eds.). Stockley's Herbal Medicines Interactions. Pharmaceutical Press 2009; 423 p.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.